ClinicalTrials.gg
RecruitingNCT07859436AUDIO-CONSENTUpdated Oct 7, 2026

Human Voice vs AI-Cloned Voice Audio Added to Written Consent Before Ureteroscopy or Retrograde Intrarenal Surgery (AUDIO-CONSENT)

An interventional study of Standard written informed consent and Human-voice audio consent recording in Urolithiasis, Kidney Calculi and Ureteral Calculi, sponsored by Aydin Adnan Menderes University. Recruiting at 3 sites in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-07.

Sponsored by Aydin Adnan Menderes University · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Started Sep 2026; still recruiting 1 month later.
Updated Oct 7, 2026Primary outcomes revisedNewly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
240
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 27 studies in Urolithiasis with a site in Turkey — 10 open to participants now, 10 under way, none of them phase 3. Urolithiasis · Turkey.

Planned enrollment
Largest of 17
240 · median 80
Started
2026
with 8 others
No phase
15 of 27
3 open now
Registered
25th of 27
by date
Lead sponsor
1 of 27
Aydin Adnan Menderes University

Among the 27 studies in Urolithiasis with a site in Turkey, this one has the largest planned enrollment of the 17 interventional ones that give a count, is one of 9 that started in 2026, is one of 15 with no phase, and was the 25th registered.

Urolithiasis

257 studies on the registry are indexed under Urolithiasis; 69 are open to participants now.

Browse Urolithiasis studies →

Open to participants now

10 of the 27 studies in Urolithiasis with a site in Turkey are open now. Recruiting first, the newest first:

4 more — sign in →

All 10 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 38 Urolithiasis studies recruiting now, 18 (47%) set no upper age limit and 12 (32%) stop at 75 or younger; 5 take children under 18; 4 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 27 studies in Urolithiasis with a site in Turkey, or all of them as a file.
02

Study summary

Before kidney stone surgery with a flexible or semirigid ureteroscope, patients must read and sign a written consent form, but many patients find these forms long and hard to understand. This study tests whether listening to an audio recording of the same consent form, in addition to the usual written form and the surgeon's explanation, helps patients understand the operation better. It also asks whether it matters if the recording is read by a real urologist or produced by artificial intelligence (AI) from a clone of that same urologist's voice.

Adults scheduled for their first ureteroscopy or retrograde intrarenal surgery at three hospitals in Turkey will be randomly assigned to one of three groups: (A) standard written consent only, (B) standard consent plus an audio recording read by a urologist, or (C) standard consent plus the same text produced by an AI-cloned version of the same urologist's voice. All three groups receive exactly the same information, word for word; only the way it is delivered differs. Patients in group C are told that the voice was produced by AI.

The main outcome is a 10-question knowledge test on the content of the consent form, taken immediately after the consent process. Anxiety (State-Trait Anxiety Inventory) and satisfaction are also measured on the same day. No forms are completed on the day of surgery.

Read the detailed description

Design: multicenter, prospective, parallel-group, three-arm (1:1:1) randomized controlled trial with outcome-assessor and analyst blinding.

Stimuli: The same unified URS/RIRS consent text is used in all arms. Arm B uses a single studio recording read by one urologist (identical at all centers; not the patients' own surgeon). Arm C uses a voice clone of the same urologist generated with Resemble.ai from a separate reference recording (≥5 min, different text), rendered once and frozen (no live AI calls). Both recordings were loudness-matched (-24.0 LUFS), mono, 48 kHz, AAC; duration 716.8 s vs 708.4 s (1.2% difference). Recordings are presented after the standard written consent process and physician explanation are completed, on a tablet with headphones; patients may replay them (replay count recorded) and may ask the physician questions in every arm. Arms B and C are introduced with structurally parallel sentences ("read by a urologist" vs "generated with AI from a urologist's voice").

Randomization: computer-generated, stratified by center (3) and education level (middle school or less / high school or higher), 6 strata, permuted blocks of varying size (block sizes not disclosed to site staff); allocation concealment by sequentially numbered, sealed, opaque envelopes; the person opening envelopes differs from the outcome scorer. Knowledge tests are scored by an assessor blinded to arm; the dataset is transferred to the statistician with masked arm labels.

Hypotheses (fixed-sequence testing, two-sided α=0.05): H1 knowledge score arm C > arm A; H2 arm B > arm A (tested only if H1 is significant); H3 arm C vs arm B - descriptive only, adjusted mean difference with 95% CI compared against a pre-specified reference range of ±1.0 point; no equivalence or non-inferiority claim will be made.

Sample size: to detect a 1.0-point difference (SD 2.0, d=0.50) with 85% power, 72 analyzable patients per arm; 80 per arm (240 total) allowing 10% loss. A blinded sample-size re-estimation (pooled SD, arm labels not revealed) is performed once after 120 patients; if pooled SD >2.3 the sample size is recalculated with the same effect, α and power.

Analysis: ANCOVA for post-consent knowledge score with arm, education, procedure, age and center; secondary ANCOVA for post-consent STAI-S (STAI-S2) adjusted for pre-consent STAI-S (STAI-S1), STAI-T, sex, education, procedure and center. Pre-specified supportive analysis: arm A vs pooled audio arms (B+C). Exploratory: education × arm interaction; physician (consenting doctor) variance. Knowledge-test psychometrics (KR-20, item difficulty, discrimination) are reported from trial data. Reporting follows CONSORT.

Analysis set: the primary analysis is performed in the modified intention-to-treat (mITT) population - all randomized patients analyzed in their allocated arm who have a measured primary outcome. If missing primary outcome data exceed 5%, a sensitivity analysis using multiple imputation is performed; a per-protocol analysis is also reported as sensitivity analysis.

03

Conditions studied

  • Urolithiasis
  • Kidney Calculi
  • Ureteral Calculi
  • Informed Consent

Keywords

  • audio informed consent
  • voice cloning
  • artificial intelligence
  • patient comprehension
  • ureteroscopy
  • retrograde intrarenal surgery
  • preoperative anxiety
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older
  • Scheduled for elective ureteroscopy (URS) or retrograde intrarenal surgery (RIRS)
  • Able to read, understand and communicate verbally in Turkish
  • Provides written to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Hearing or visual impairment preventing use of the study materials
  • Confusion, dementia, psychosis or any other condition affecting capacity to consent
  • Emergency surgery
  • Previous URS or RIRS
  • Current psychiatric treatment or use of anxiolytics
  • Health-care professional
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
240 participants (estimated)

Study arms

  • Active comparator
    A: Written consent (standard care)

    Standard care: the unified written consent form plus the physician's usual verbal explanation. No audio recording.

    Other: Standard written informed consent

  • Experimental
    B: Written consent + urologist-read audio

    Standard care plus an audio recording of the entire consent text read by a urologist (the same recording at all centers), presented after the standard consent process.

    Other: Standard written informed consent · Behavioral: Human-voice audio consent recording

  • Experimental
    C: Written consent + AI-cloned voice audio

    Standard care plus an audio recording of the same text generated with AI from a voice clone of the same urologist, presented after the standard consent process; patients are told that the voice was generated with AI.

    Other: Standard written informed consent · Behavioral: AI-cloned-voice audio consent recording

Interventions

  • OtherStandard written informed consent

    The institution's unified written informed consent form for ureteroscopy and retrograde intrarenal surgery, read and signed by the patient, together with the physician's usual verbal explanation. Delivered identically in all three arms.

  • BehavioralHuman-voice audio consent recording

    An approximately 12-minute audio recording of the complete consent text, read word for word by one urologist (the same recording at all centers; not the patient's own surgeon). Presented after the standard written consent and physician explanation, on a tablet with headphones in the patient's room without companions; the patient may replay it and the number of replays is recorded. Loudness-normalized to -24 LUFS. Introduced to the patient as "a recording of the entire consent form read by a urologist".

  • BehavioralAI-cloned-voice audio consent recording

    The same consent text, generated once with Resemble.ai from a voice clone of the same urologist (reference sample: a separate recording of at least 5 minutes of a different text), frozen before enrollment with no live AI calls. Duration approximately 12 minutes; loudness-matched (-24 LUFS), codec and delivery identical to the human-voice recording, presented after the standard written consent and physician explanation, on a tablet with headphones; replay allowed and counted. Patients are informed that the voice was generated with AI from a urologist's voice.

06

What researchers measure

Primary outcomes

  1. Post-consent knowledge score

    Score on a 10-item multiple-choice test derived from the consent text (range 0-10; higher scores indicate better knowledge of the procedure, its risks, alternatives and patient responsibilities). Each item is mapped to a specific paragraph of the consent form. Analyzed as a continuous variable.

    Time frame: Day of consent, immediately after completion of the consent process (before surgery)

Secondary outcomes

  1. Post-consent state anxiety (STAI-S)

    State-Trait Anxiety Inventory, State form (Turkish version, Öner \& Le Compte), range 20-80; higher scores indicate greater anxiety. Measured immediately after the consent process and analyzed adjusted for the pre-consent STAI-S score (measured immediately before the consent process) and STAI-T.

    Time frame: Day of consent, immediately after the consent process

  2. Patient satisfaction and perceived clarity

    Three study-specific 5-point items (perceived clarity of the information, adequacy of the information for decision-making, overall satisfaction with the consent process); each scored 1-5, higher scores indicate better outcomes. Reported item by item; total score (3-15) secondary. Not validated.

    Time frame: Day of consent, immediately after the consent process

  3. Perceived naturalness and usefulness of the audio recording (arms B and C)

    Two study-specific 5-point items: naturalness of the voice (1 = not at all natural to 5 = completely natural) and usefulness of receiving the information as audio (1 = not at all to 5 = very much). Higher scores indicate greater perceived naturalness/usefulness. Asked in both audio arms.

    Time frame: Day of consent, immediately after the consent process

  4. Acceptability of the AI-generated voice (arm C)

    Single study-specific 5-point item: "Did it bother you that the voice was generated by artificial intelligence?" (1 = not at all to 5 = very much; higher scores indicate lower acceptability). Administered on a separate sheet after the naturalness items have been collected.

    Time frame: Day of consent, immediately after the consent process

  5. Number of audio replays (arms B and C)

    Number of times the patient chose to replay the audio recording.

    Time frame: Day of consent (during the consent session)

  6. Self-reported reading of the written consent form

    Single item with four categories: read all of it / read most of it / skimmed it / did not read it.

    Time frame: Day of consent, immediately after the consent process

  7. Withdrawal from or postponement of the planned procedure

    Number and percentage of patients who decline or postpone the planned surgery after the consent process, and of patients who stop the audio recording before completion. Reported descriptively by arm; not interpreted as an adverse outcome.

    Time frame: From the consent process to the scheduled date of surgery (up to 7 days)

07

Study locations

3 of 3 sites recruiting
  • Aydin Adnan Menderes University, Department of Urology
    Aydin, Aydın, Turkey (Türkiye)
    Recruiting
    • Cagatay Ozsoy, MD · Principal investigator
  • Aydin City Hospital, Department of Urology
    Aydin, Aydın, Turkey (Türkiye)
    Recruiting
    • Ahmet Emre Yildiz, MD · Principal investigator
  • Kutahya Health Sciences University, Department of Urology
    Kütahya, Kütahya, Turkey (Türkiye)
    Recruiting
    • Seref Coser, MD · Principal investigator
08

References and documents

Publications

  • Sun Y, Xu S, Jin H, Han X, Jin K, Zhang Y, Ma X, Wei H, Ma M. Effectiveness of Al-Assisted Patient Health Education Using Voice Cloning and ChatGPT: Prospective Randomized Controlled Trial. J Med Internet Res. 2026 Mar 19;28:e81387. doi: 10.2196/81387. PubMed 41855493 ↗
  • Haack M, Fischer ND, Frey L, Sparwasser P, Dotzauer R, Duwe G, Haferkamp A, Borgmann H. Digital informed consent for urological surgery - randomized controlled study comparing multimedia-supported vs. traditional paper-based informed consent concerning satisfaction, anxiety, information gain and time efficiency. Prostate Cancer Prostatic Dis. 2024 Dec;27(4):715-719. doi: 10.1038/s41391-023-00737-4. Epub 2023 Nov 4. PubMed 37925488 ↗
  • Goldberger JJ, Kruse J, Kadish AH, Passman R, Bergner DW. Effect of informed consent format on patient anxiety, knowledge, and satisfaction. Am Heart J. 2011 Oct;162(4):780-785.e1. doi: 10.1016/j.ahj.2011.07.006. Epub 2011 Sep 14. PubMed 21982673 ↗
  • Glaser J, Nouri S, Fernandez A, Sudore RL, Schillinger D, Klein-Fedyshin M, Schenker Y. Interventions to Improve Patient Comprehension in Informed Consent for Medical and Surgical Procedures: An Updated Systematic Review. Med Decis Making. 2020 Feb;40(2):119-143. doi: 10.1177/0272989X19896348. Epub 2020 Jan 16. PubMed 31948345 ↗

Individual participant data

Plan to share: Yes — Fully anonymized individual participant data underlying the results reported in publications (knowledge test item scores, STAI scores, questionnaire responses and baseline covariates), together with the data dictionary. Direct and indirect identifiers will be removed or aggregated before sharing.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Beginning 6 months after publication of the primary results.

Access criteria: Researchers who submit a methodologically sound proposal to the principal investigator. Data are shared after approval of the proposal, approval by the responsible ethics committee where required, and signing of a data-sharing agreement, in accordance with Turkish personal data protection law (KVKK).

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2026 (actual). Primary completion is estimated for Mar 2027, 6 months after the start.

Of 88 non-industry interventional studies with no phase under Urolithiasis, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 39. This study's planned 6 months is below that.

Counting every sponsor, half of 98 studies reached it within 19 months; a quarter within 8 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 30, 2026
First posted
Oct 5, 2026
StartActual
Sep 28, 2026
Primary completionEst.
Mar 2027
CompletionEst.
Apr 2027
Last update
Oct 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary outcomes
1 time frame changed
What changed in the outcomes
  • Time framePost-consent knowledge scoreImmediately after completion of the consent process (day of consent, before surgery) → Day of consent, immediately after completion of the consent process (before surgery)
Oct 7, 2026
Secondary outcomes
7 time frame changed, 1 description edited
What changed in the outcomes
  • Time framePost-consent state anxiety (STAI-S)Immediately after the consent process (same day) → Day of consent, immediately after the consent process
  • Time framePatient satisfaction and perceived clarityImmediately after the consent process (same day) → Day of consent, immediately after the consent process
  • Time framePerceived naturalness and usefulness of the audio recording (arms B and C)Immediately after the consent process (same day) → Day of consent, immediately after the consent process
  • Time frameAcceptability of the AI-generated voice (arm C)Immediately after the consent process (same day) → Day of consent, immediately after the consent process
  • Time frameNumber of audio replays (arms B and C)During the consent process (same day) → Day of consent (during the consent session)
  • Time frameSelf-reported reading of the written consent formImmediately after the consent process (same day) → Day of consent, immediately after the consent process
  • Time frameWithdrawal from or postponement of the planned procedureFrom the consent process to the scheduled date of surgery → From the consent process to the scheduled date of surgery (up to 7 days)
  • DescriptionPatient satisfaction and perceived clarity: how it is measured was reworded
Oct 7, 2026
Registered
First appeared on the registry
Oct 5, 2026
Show all 2 updates
  1. Oct 7, 2026
    Primary outcomes 1 time frame changed
    What changed in the outcomes
    • Time framePost-consent knowledge scoreImmediately after completion of the consent process (day of consent, before surgery) → Day of consent, immediately after completion of the consent process (before surgery)
    Secondary outcomes 7 time frame changed, 1 description edited
    What changed in the outcomes
    • Time framePost-consent state anxiety (STAI-S)Immediately after the consent process (same day) → Day of consent, immediately after the consent process
    • Time framePatient satisfaction and perceived clarityImmediately after the consent process (same day) → Day of consent, immediately after the consent process
    • Time framePerceived naturalness and usefulness of the audio recording (arms B and C)Immediately after the consent process (same day) → Day of consent, immediately after the consent process
    • Time frameAcceptability of the AI-generated voice (arm C)Immediately after the consent process (same day) → Day of consent, immediately after the consent process
    • Time frameNumber of audio replays (arms B and C)During the consent process (same day) → Day of consent (during the consent session)
    • Time frameSelf-reported reading of the written consent formImmediately after the consent process (same day) → Day of consent, immediately after the consent process
    • Time frameWithdrawal from or postponement of the planned procedureFrom the consent process to the scheduled date of surgery → From the consent process to the scheduled date of surgery (up to 7 days)
    • DescriptionPatient satisfaction and perceived clarity: how it is measured was reworded
    + 2 other changes: verification date and description
  2. Oct 5, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07859436
Collaborators
Aydin City Hospital, Kutahya Health Sciences University
Responsible party
Ahmet Emre YILDIZ (Urology Specialist, MD, Aydin Adnan Menderes University) — Principal investigator
First posted
Oct 5, 2026
Start date
Sep 28, 2026
Primary completion
Mar 2027 (estimated)
Completion
Apr 2027 (estimated)
Last update
Oct 7, 2026

Study contacts

Ahmet Emre Yildiz, MD
Contact
aemreyildiz@gmail.com
+90 535 312 98 32
Ahmet Emre Yildiz, MD
principal investigator · Aydin City Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion